Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway

Annals of Oncology : Official Journal of the European Society for Medical Oncology
L A DeGraffenriedM Hidalgo

Abstract

The PTEN protein is a lipid phosphatase with putative tumor suppressing abilities, including inhibition of the PI3K/Akt signaling pathway. Inactivating mutations or deletions of the PTEN gene, which result in hyper-activation of the PI3K/Akt signaling pathway, are increasingly being reported in human malignancies, including breast cancer, and have been related to features of poor prognosis and resistance to chemotherapy and hormone therapy. Prior studies in different tumor models have shown that, under conditions of PTEN deficiency, the PI3K/Akt signaling pathway becomes a fundamental proliferative and survival pathway, and that pharmacological inhibition of this pathway results in tumor growth inhibition. This study aimed to explore further this hypothesis in breast cancer cells. To this end, we have determined the growth response to inhibition of the PI3K/Akt signaling pathway in a series of breast cancer cell lines with different PTEN levels. The PTEN-negative cell line displayed greater sensitivity to the growth inhibitory effects of the PI3K inhibitor, LY294002 and rapamycin, an inhibitor of the PI3K/Akt downstream mediator mTOR, compared with the PTEN-positive cell lines. To determine whether or not these differences in r...Continue Reading

References

Aug 1, 1997·Nature Genetics·D J MarshC Eng
Jan 5, 2000·Breast Cancer Research and Treatment·J M GarciaF Bonilla
Feb 29, 2000·Cell·A Di Cristofano, P P Pandolfi
Apr 27, 2000·The Journal of Surgical Research·R A PeruginiM P Callery
Mar 10, 2001·Experimental Cell Research·L Simpson, R Parsons
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·K PodsypaninaR Parsons
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·M S NeshatC L Sawyers
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Linda A deGraffenriedManuel Hidalgo

❮ Previous
Next ❯

Citations

Aug 10, 2006·Breast Cancer Research and Treatment·Miltiadis Paliouras, Eleftherios P Diamandis
Mar 27, 2007·Pharmaceutical Research·Renu M Stephen, Robert J Gillies
Mar 30, 2007·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Qingyong ChenDaoda Chen
Sep 18, 2013·Cancer Letters·Brigette B Y MaAnthony T C Chan
Mar 23, 2005·Current Opinion in Cell Biology·Matthias P Wymann, Romina Marone
Sep 18, 2007·Nature Medicine·Teresa PalomeroAdolfo A Ferrando
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
May 1, 2010·Japanese Journal of Clinical Oncology·Yasuhito FujisakaTomohide Tamura
Aug 13, 2005·Anti-cancer Drugs·Daniel Morgensztern, Howard L McLeod
Apr 15, 2011·The Journal of Clinical Investigation·Seth A WanderJoyce M Slingerland
Oct 29, 2009·Journal of Hematology & Oncology·Ruirong YuanDavid Lebwohl
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo
Jun 28, 2006·Biological Chemistry·Miltiadis Paliouras, Eleftherios P Diamandis
May 9, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Young Ho LeeGwan Gyu Song
Aug 30, 2008·Journal of Cancer Research and Clinical Oncology·Shigeru KandaYasuyoshi Miyata
Aug 13, 2008·Expert Opinion on Therapeutic Targets·Linda S SteelmanJames A McCubrey
Sep 23, 2006·Expert Opinion on Investigational Drugs·Piotr Smolewski
Oct 17, 2008·Expert Opinion on Investigational Drugs·Angelica Fasolo, Cristiana Sessa
Sep 21, 2013·Current Medical Research and Opinion·Mehmet A N SendurKadri Altundag
Dec 17, 2015·Endocrine-related Cancer·Maria Chiara ZatelliUNKNOWN NIKE Group
Aug 6, 2011·International Journal of Radiation Oncology, Biology, Physics·Sofie F IsebaertKarin M Haustermans
Jan 22, 2011·Trends in Molecular Medicine·Andrea MorandiClare M Isacke
Nov 18, 2008·Cancer Treatment Reviews·Alex S StrimpakosKostas N Syrigos
Dec 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Akram SadeghiriziSafiyeh Aghazadeh
Mar 14, 2007·Biochemical and Biophysical Research Communications·Hiroo NakajimaNaruhiko Mizuta
Feb 6, 2007·Cancer Letters·Miltiadis PaliourasEleftherios P Diamandis

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Linda A deGraffenriedManuel Hidalgo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
E RaymondJean-Pierre Armand
Annals of Oncology : Official Journal of the European Society for Medical Oncology
S VignotE Raymond
© 2021 Meta ULC. All rights reserved